Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Expanded Access Policy for Investigational Drugs
Families
Healthcare Professionals
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Subscribe
Contact Us
Career
En
Sv
Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Expanded Access Policy for Investigational Drugs
Families
Healthcare Professionals
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Subscribe
Contact Us
Career
Press releases
Prospectus relating to Infant Bacterial Therapeutics’ rights issue published
January 10, 2018
To access the press release, please read the following disclaimer
here
.
Latest press releases
2025-11-13 07:30
Infant Bacterial Therapeutics AB (publ) Interim report January 1 – September 30, 2025
Regulatory
2025-10-20 10:35
Infant Bacterial Therapeutics AB (publ) announces the appointment of the Nomination Committee for the Annual General Meeting 2026
Regulatory
2025-10-13 14:35
Registration work for IBT's drug candidate IBP-9414 continues in the US and Europe
2025-09-10 09:38
IBT presented “Avoiding the severe consequences of NEC” at the NEC Society Symposium in Chicago
2025-08-20 08:00
Infant Bacterial Therapeutics AB (publ) Interim report January 1 – June 30, 2025
Regulatory